Adagene and Exelixis reach milestone in SAFEbody ADC collaboration
Adagene announced it achieved a milestone in its ongoing collaboration with Exelixis to advance SAFEbody antibody-drug conjugate candidates.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Adagene milestone in collaboration with Exelixis on SAFEbody ADC candidates
Adagene says it achieved a milestone in its collaboration with Exelixis to advance SAFEbody antibody-drug conjugate candidates.